|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 2100 PENNSYLVANIA AVENUE, NW |
Address2 | SUITE 500 |
| City | WASHINGTON |
State | DC |
Zip Code | 20037 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 12675-24
|
||||||||
|
6. House ID# 318110010
|
||||||||
| TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Michael S. Berman, President |
Date | 01/20/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Implementation of Patient Protection and Affordable Care Act PL 111-148 and PL 111-152 - Executive Branch actions re this issues.
*Funding for HHS programs and agencies - HR 2055, Consolidated Appropriations Act, 2012; S 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012.
*Medical Liability reform - HR 5, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011; S 197, MCAP Act; S 218, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011; S 1099, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011.
*Data Security - HR 611, BEST PRACTICES Act; HR 1707, Data Accountability and Trust Act; HR 1841, Data Accountability and Trust Act (DATA) of 2011; HR 2577, SAFE Data Act; S 1207, Data Security and Breach Notification Act of 2011; S 1408, Data Breach Notification Act of 2011; S 1535, Personal Data Protection and Breach Accountability Act of 2011.
*Antitrust exemption for physicians - HR 1409, Quality Health Care Coalition Act of 2011; HR 1173, Fiscal Responsibility and Retirement Security Act of 2011.
*Repeal of premium tax and other ACA provisions - HR 2676, Small Business Health Relief Act of 2011; S 1049, Small Business Health Relief Act of 2011.
*Repeal of 3 percent withholding rate - HR 674, To amend the Internal Revenue Code of 1986 to repeal the imposition of 3 percent withholding on certain payments made to vendors by government entities.
*Privacy, data security - S 1151, Personal Data Privacy and Security Act of 2011.
*Eligibility for healthcare assistance - HR 2576, To amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs; HR 2055, Consolidated Appropriations Act, 2012.
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Berman |
|
|
|
Steven |
Champlin |
|
|
|
Kenneth |
Duberstein |
|
|
|
Brian |
Griffin |
|
|
|
Daniel |
Meyer |
|
|
|
Marti |
Thomas |
|
|
|
Eric |
Ueland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
*LTC insurance reforms - HR 63, Long-Term Care Insurance Reform Act of 2011; S 159, Confidence in Long-Term Care Insurance Act of 2011.
*Minimum hospital stays for matectomy patients - HR 111, Breast Cancer Patient Protection Act of 2011.
*National marketplace for individual coverage - HR 346, Health Care Choice Act of 2011; HR 371, Health Care Choice Act of 2011.
*Rate review - HR 416, Health Insurance Rate Review Act; S 137, Health Insurance Rate Review Act.
*Association health plans - HR 1050, Small Business Health Fairness Act of 2011.
*Antitrust policy - HR 1150, Competitive Health Insurance Reform Act of 2011.
*Agent commissions, medical loss ratios - HR 1206, Access to Professional Health Insurance Advisors Act of 2011.
*Changes to McCarran-Ferguson Act - HR 1943, Health Insurance Industry Fair Competition Act.
*Medical loss ratios - HR 2077, MLR Repeal Act of 2011.
*MLRs for Medigap policies - HR 2645, Medigap Medical Loss Ratio Improvement Act; S 1416, Medigap Medical Loss Ratio Improvement Act of 2011.
*Disability program for Federal employees - HR 2958, Federal Employee Short-Term Disability Insurance Act of 2011.
*Enrollment period for child-only policies - S 1500, Ensure Children Have Health Care Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Berman |
|
|
|
Steven |
Champlin |
|
|
|
Kenneth |
Duberstein |
|
|
|
Brian |
Griffin |
|
|
|
Daniel |
Meyer |
|
|
|
Marti |
Thomas |
|
|
|
Eric |
Ueland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Impact of deficit reduction issues and actions of the Joint Committee on Deficit Reduction on Medicare and Medicare Part D - Proposed legislation re these issues.
Sustainable growth rate and impact on other Medicare programs; *Medicare physician payment, extension of QI and TMA programs; *budget offsets - HR 3630, Temporary Payroll Tax Cut Continuation Act of 2011; HR 3765, Temporary Payroll Tax Cut Continuation Act of 2011.
Potential changes to Medicare Advantage - Proposed legislation re this issue.
*Part D price negotiation - S 31, Prescription Drug and Health Improvement Act of 2011; S 44, Medicare Prescription Drug Price Negotiation Act of 2011; HR 2248, Medicare Prescription Drug Price Negotiation Act of 2011; HR 3399, Medicare and Medicaid FAST Act; HR 3519, To amend to exempt the Medicare program from fallback sequestration under the Budget Control Act of 2011; HR 3630, Temporary Payroll Tax Cut Continuation Act of 2011; HR 3691, Senior Medicare Fairness Act of 2011; HR 3765, Temporary Payroll Tax Cut Continuation Act of 2011.
*Medicare Part D changes - HR 999, Medicare Prescription Drug Savings and Choice Act of 2011; S 560, Medicare Prescription Drug Savings and Choice Act of 2011.
*Medicare secondary payer rules - HR 1063, Strengthening Medicare And Repaying Taxpayers Act of 2011.
*Medicare Advantage enrollment periods - HR 1580, Medicare Beneficiary Preservation of Choice Act of 2011; S 1479, Medicare Beneficiary Preservation of Choice Act of 2011; HR 1357, Puerto Rico Medicare Part B Equity Act of 2011.
*Rebates for dual eligibles - HR 2190, Medicare Drug Savings Act of 2011; S 1206, Medicare Drug Savings Act of 2011.
*Strengthening Medicare anti-fraud measures - HR 675, Strengthening Medicare Anti-Fraud Measures Act of 2011.
*Extension of Medicare cost plans - HR 2770, Medicare Cost Contract Extension Act of 2011; S 1497, Medicare Cost Contract Extension Act of 2011.
*Medicare and Medicaid fraud and abuse - S 1251, Medicare and Medicaid FAST Act.
*Budget offsets - S 1944, Middle Class Tax Cut Act of 2011; S 1931, Temporary Tax Holiday and Government Reduction Act.
*Frailty adjuster for certain MA SNPs - S 1999, Senior Medicare Fairness Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Berman |
|
|
|
Steven |
Champlin |
|
|
|
Kenneth |
Duberstein |
|
|
|
Brian |
Griffin |
|
|
|
Daniel |
Meyer |
|
|
|
Marti |
Thomas |
|
|
|
Eric |
Ueland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
*HSA improvements - HR 369, Health Savings and Affordability Act of 2011.
*Repeal of HSA restrictions - HR 524, Restoring Consumer-driven Health Care Act of 2011.
*Repeal of HSA and FSA restrictions - HR 450, Restoring Assistance for Families' and Seniors' Health Expenses Act of 2011; HR 605, Patients' Freedom to Choose Act; S 312, Patients' Freedom to Choose Act.
*HSA and FSA improvements - HR 2010, Family and Retirement Health Investment Act of 2011; S 1098, Family and Retirement Health Investment Act of 2011.
*Healthcare reform, including premium tax repeal - HR 1370, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
*Use of HSA and FSA funds to purchase OTC medications - HR 2529, Restoring Access to Medication Act; S 1368, Restoring Access to Medication Act.
*TAA health coverage tax credits - HR 2832, To extend the Generalized System of Preferences, and for other purposes.
*Health insurance premium tax - S 1880, Jobs and Premium Protection Act.
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Berman |
|
|
|
Steven |
Champlin |
|
|
|
Kenneth |
Duberstein |
|
|
|
Brian |
Griffin |
|
|
|
Daniel |
Meyer |
|
|
|
Marti |
Thomas |
|
|
|
Eric |
Ueland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
*FEHBP prescription drugs - HR 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act.
*Pay-for-delay settlements - S 27, Preserve Access to Affordable Generics Act.
*Antitrust exemption for independent pharmacies - HR 1946, Preserving Our Hometown Independent Pharmacies Act of 2011.
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Berman |
|
|
|
Steven |
Champlin |
|
|
|
Kenneth |
Duberstein |
|
|
|
Brian |
Griffin |
|
|
|
Daniel |
Meyer |
|
|
|
Marti |
Thomas |
|
|
|
Eric |
Ueland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |